Developability of Biopharmaceuticals

-

By accounting for developability in candidate selection, drug developers have the potential to greatly minimize costly attrition and reduce development time significantly. However, this rapidly expanding area is not without its challenges, and key issues surrounding the early implementation of molecular assessments and rational engineering approaches need to be addressed.

Developability of Biopharmaceuticals has been designed to support drug developers in reducing the cost, risk and time of development. Our agenda focuses on the opportunities such as monitoring protein thermostability to ensure optimal conditions for bioprocess and exploring new high throughput screening methods to improve confidence in candidate selection.

Location:
Revere Hotel
USA


Organizer: Hanson Wade

4 Dec 2012



All Upcoming Events
1 2 3 Next 
Microscopy & Microanalysis2 Aug 2015
WMIC 20152 Sep 2015
World Drug Safety Congress Europe8 Sep 2015
MSACL 2015 EU8 Sep 2015
ASHG 20156 Oct 2015
Neuroscience 201517 Oct 2015
BioData World Congress21 Oct 2015
AAPS 201525 Oct 2015
Medica 201516 Nov 2015
ASCB 201512 Dec 2015

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement